Press release

Change to the shareholder structure of the Galenica Group

Wednesday, 11 May 2016, ↓ directly to download

KKR and Stefano Pessina reduce the stake held through Sprint Investments 2 GmbH from 25% to slightly above 20%, thereby significantly increasing the free float of the Galenica share (shares in circulation).

In 1999, the Galenica Group and Alliance Boots formed a strategic partnership that granted Alliance Boots a 25% stake in the Galenica Group. Although the ownership structure of the share package changed with the investment of private equity firm KKR in 2007 and the merger of Alliance Boots and Walgreens in 2014 – it is currently held by Sprint Investments 2 GmbH – KKR and Stefano Pessina have continued to assist and support Galenica in recent years.

Read more

Galenica is a diversified Group active throughout the healthcare market which, among other activities, develops, manufactures and markets pharmaceutical products, runs pharmacies, provides logistical and database services and sets up networks. With its two Business units Vifor Pharma and Galenica Santé, the Galenica Group enjoys a leading position in all its core business activities. A large part of the Group’s income is generated by international operations. Galenica is listed on the Swiss Stock Exchange (SIX Swiss Exchange, GALN, security number 1,553,646).

contact

Christina Hertig

Christina Hertig

Head of Corporate Communications


Galenica Ltd.

Corp. Communications
Untermattweg 8
CH-3027 Bern

Phone:
+41 58 852 85 17
Fax:
+41 58 852 85 58

Julien Vignot

Julien Vignot

Head Investor Relations


Galenica Ltd.

Investor Relations
Untermattweg 8
CH-3027 Bern

Phone:
+41 58 852 81 11
Fax:
+41 58 852 81 12

Send link

Send as link



Links

  •